Overview

d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis

Status:
Completed
Trial end date:
2019-10-02
Target enrollment:
Participant gender:
Summary
The Researchers are trying to determine if 68Ga-DOTATATE PET/CT imaging will have a similar accuracy as 18FDG PET/CT in diagnosing cardiac sarcoidosis and if it will be able to do so without the need for complex patient dietary preparation that is required with 18FDG PET/CT.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Fluorodeoxyglucose F18